Microsporidiosis
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Microsporidiosis | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Diarrhea, abdominal pain, weight loss, fever |
| Complications | Malabsorption, dehydration |
| Onset | Variable, often acute |
| Duration | Can be chronic in immunocompromised individuals |
| Types | N/A |
| Causes | Infection by Microsporidia |
| Risks | Immunocompromised status, HIV/AIDS, organ transplantation |
| Diagnosis | Microscopy, PCR, biopsy |
| Differential diagnosis | Cryptosporidiosis, Giardiasis, Amebiasis |
| Prevention | Safe drinking water, hand hygiene |
| Treatment | Albendazole, Fumagillin |
| Medication | N/A |
| Prognosis | Generally good in immunocompetent individuals |
| Frequency | More common in developing countries |
| Deaths | N/A |
Microsporidiosis is an infection caused by microsporidia, a group of spore-forming unicellular parasites. These organisms are known to infect a wide range of hosts, including humans, and are particularly significant in immunocompromised individuals.
Etiology
Microsporidiosis is caused by various species of microsporidia, with the most common human pathogens being Enterocytozoon bieneusi and Encephalitozoon intestinalis. These organisms are obligate intracellular parasites, meaning they must live within the cells of their host to survive and reproduce.
Transmission
The primary mode of transmission of microsporidiosis is through the ingestion of spores, which can be found in contaminated food and water. Person-to-person transmission can also occur, particularly in settings with poor sanitation. In addition, zoonotic transmission from animals to humans has been documented.
Pathogenesis
Once ingested, the spores of microsporidia infect the epithelial cells of the gastrointestinal tract. The spores extrude a polar tubule that penetrates the host cell membrane, allowing the parasite to inject its sporoplasm into the host cell. Inside the host cell, the microsporidia replicate and eventually cause cell lysis, releasing new spores to infect other cells.
Clinical Manifestations
The clinical presentation of microsporidiosis can vary depending on the species involved and the immune status of the host. In immunocompetent individuals, the infection may be asymptomatic or cause mild, self-limiting gastrointestinal symptoms such as diarrhea. In immunocompromised individuals, such as those with HIV/AIDS or undergoing immunosuppressive therapy, the infection can be more severe and disseminate to other organs, causing symptoms such as:
- Chronic diarrhea
- Malabsorption
- Weight loss
- Hepatitis
- Sinusitis
- Keratoconjunctivitis
Diagnosis
Diagnosis of microsporidiosis typically involves the identification of microsporidia spores in stool samples, urine, or tissue biopsies. Techniques used for diagnosis include:
- Light microscopy with special stains (e.g., modified trichrome stain)
- Electron microscopy
- Polymerase chain reaction (PCR) assays
Treatment
The treatment of microsporidiosis depends on the species involved and the immune status of the patient. Commonly used medications include:
- Albendazole: Effective against Encephalitozoon species.
- Fumagillin: Used for infections caused by Enterocytozoon bieneusi.
In immunocompromised patients, improving immune function through antiretroviral therapy (in the case of HIV/AIDS) can also help control the infection.
Prevention
Preventive measures for microsporidiosis include:
- Ensuring access to clean water and proper sanitation
- Practicing good hygiene, such as handwashing
- Avoiding consumption of potentially contaminated food and water
Epidemiology
Microsporidiosis is a global disease, with higher prevalence in areas with poor sanitation and among immunocompromised populations. The true prevalence is likely underreported due to the difficulty in diagnosing the infection.
See Also
References
External Links
This article is a Infectious disease-related stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD